跳至主要内容
临床试验/NCT07541664
NCT07541664招募中不适用

Effectiveness and Safety of a Digital Mind-Body Therapy Based on Digital Music and Biofeedback in Patients With Locally Advanced Breast Cancer Undergoing Neoadjuvant Treatment

Fudan University1 个研究点 分布在 1 个国家目标入组 66 人开始时间: 2026年3月25日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
66
试验地点
1
主要终点
Insomnia severity

研究概览

简要总结

This study is a single-center, randomized controlled, prospective trial investigating the application of Digital Mind-Body Therapy based on digital music and biofeedback (DMBT) during neoadjuvant treatment in patients with locally advanced breast cancer.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Participants voluntarily agree to take part in this study and provide written informed consent.
  • Female, aged ≥18 years.
  • Histologically confirmed invasive breast cancer.
  • Planned to receive neoadjuvant therapy.
  • Completion of psychosomatic assessment prior to initiation of neoadjuvant therapy, with at least two of the following domains reaching mild or higher severity: anxiety, depression, insomnia, or psychological distress (severity classified according to established clinical cut-off values of the respective assessment scales).
  • Good compliance and willingness to adhere to follow-up.
  • Normal hearing, without severe hearing impairment.
  • Possession of a smartphone and ability to independently operate mobile applications.

排除标准

  • Presence of distant metastasis.
  • History of other malignancies, except for adequately treated basal cell carcinoma or squamous cell carcinoma of the skin, carcinoma in situ of the cervix, or other cancers with disease-free survival >5 years.
  • Immunodeficiency or human immunodeficiency virus (HIV) infection.
  • Severe dysfunction of the heart, lungs, liver, or kidneys.
  • Uncontrolled infection or active infection.
  • Pregnant or lactating women.
  • Markedly abnormal psychological or cognitive status that precludes completion of psychosomatic assessment.
  • Prior diagnosis of bipolar disorder, schizophrenia, schizoaffective disorder, or other psychiatric disorders secondary to medical conditions.

研究组 & 干预措施

Control Arm

No Intervention

If a patient has locally advanced breast cancer, requires neoadjuvant therapy, and is randomly assigned to the control arm

Experimental Arm

Experimental

If a patient has locally advanced breast cancer, requires neoadjuvant therapy, and is randomly assigned to the experimental arm

干预措施: DMBT (Behavioral)

结局指标

主要结局

Insomnia severity

时间窗: Baseline and up to 24 weeks

Sleep disturbance assessed by Insomnia Severity Index(ISI)

次要结局

  • Distress(Baseline and up to 24 weeks)
  • Depression(Baseline and up to 24 weeks)
  • Anxiety(Baseline and up to 24 weeks)
  • QoL(Baseline and up to 24 weeks)
  • Cognitive function(Baseline and up to 24 weeks)
  • Cancer-related fatigue(Baseline and up to 24 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Zhimin Shao

Professor

Fudan University

研究点 (1)

Loading locations...

相似试验